Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
level increased » levels increased (Expand Search), levels decreased (Expand Search), gene increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
level increased » levels increased (Expand Search), levels decreased (Expand Search), gene increased (Expand Search)
-
1841
-
1842
Restricted cubic spline plots showing the association between changes in PAL and risk of CVD.
Published 2025Subjects: -
1843
-
1844
-
1845
-
1846
-
1847
-
1848
-
1849
-
1850
Including non-sigmoidal melting curves in peptide-level TPP-TR datasets largely increases the number of discoveries.
Published 2024“…(A) Considering non-conventional melting curves in the analysis makes it possible to include almost twice (1.78) as many phospho-peptides compared to the published melting point (<i>T</i><sub><i>m</i></sub>) analysis. (B) By increasing the phospho-peptides coverage, GPMelt captures about five times more (4.9) mono-phosphorylated peptides than the published <i>T</i><sub><i>m</i></sub> analysis, and captures phosphosites associated with significantly higher functional scores than non-captured phosphosites (one-sided Wilcoxon signed-rank test). …”
-
1851
-
1852
Identification and validation of <i>Ctsz</i> as the lead candidate gene underlying <i>Tip5.</i>
Published 2025Subjects: -
1853
-
1854
The association between procalcitonin levels and mortality in patients with AECOPD.
Published 2024Subjects: -
1855
IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors.
Published 2025Subjects: -
1856
-
1857
IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors.
Published 2025Subjects: -
1858
-
1859
Growth of certain cancer cell lines requires IRE1 but not its enzymatic activity.
Published 2025Subjects: -
1860